Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia

OBJECTIVE: This study sought to examine the effect of ziprasidone on olanzapine or clozapine associated medical morbidity such as insulin resistance, diabetes mellitus and impaired fasting glucose, obesity and hyperlipidemia in patients with schizophrenia or schizoaffective disorder. METHOD: This wa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Psychopharmacol
Autors principals: Henderson, David C., Fan, Xiaoduo, Copeland, Paul M., Sharma, Bikash, Borba, Christina P., Forstbauer, Sharon I., Miley, Kate, Boxill, Ryan, Freudenreich, Oliver, Cather, Corey, Evins, A. Eden, Goff, Donald C.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4327763/
https://ncbi.nlm.nih.gov/pubmed/19283774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hup.1012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars